Cited by 943Lymphatic System and DiseasesLymphatic Disorders and TreatmentsVascular Malformations and Hemangiomas

An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype

Open access
Wigle, Jeffrey T., Harvey, Natasha, Detmar, Michael, Lagutina, Irina, Grosveld, Gerard, Gunn, Michael D., Jackson, David G., Oliver, Guillermo·2002·The EMBO Journal

Abstract

The process of angiogenesis has been well documented, but little is known about the biology of lymphatic endothelial cells and the molecular mechanisms controlling lymphangiogenesis. The homeobox gene Prox1 is expressed in a subpopulation of endothelial cells that, after budding from veins, gives rise to the mammalian lymphatic system. In Prox1(-)(/-) embryos, this budding becomes arrested at around embryonic day (E)11.5, resulting in embryos without lymphatic vasculature. Unlike the endothelial cells that bud off in E11.5 wild-type embryos, those of Prox1-null embryos did not co-express any lymphatic markers such as VEGFR-3, LYVE-1 or SLC. Instead, the mutant cells appeared to have a blood vascular phenotype, as determined by their expression of laminin and CD34. These results suggest that Prox1 activity is required for both maintenance of the budding of the venous endothelial cells and differentiation toward the lymphatic phenotype. On the basis of our findings, we propose that a blood vascular phenotype is the default fate of budding embryonic venous endothelial cells; upon expression of Prox1, these budding cells adopt a lymphatic vasculature phenotype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/emboj/21.7.1505

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Gunn,M.D., Tangemann,K., Tam,C., Cyster,J.G., Rosen,S.D. and Williams,L.T. (1998) A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl Acad. Sci. USA, 95, 258±263.
  2. Kaipainen,A., Korhonen,J., Mustonen,T., van Hinsbergh,V.W., Fang, G.H., Dumont,D., Breitman,M. and Alitalo,K. (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl Acad. Sci. USA, 92, 3566±3570.
  3. Paal,E., Thompson,L.D. and Heffess,C.S. (1998) A clinicopathologic and immunohistochemical study of ten pancreatic lymphangiomas and a review of the literature. Cancer, 82, 2150±2158.
  4. Streit,M., Riccardi,L., Velasco,P., Brown,L.F., Hawighorst,T., Bornstein, P. and Detmar,M. (1999) Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc. Natl Acad. Sci. USA, 96, 14888±14893.

Cited by

Sorted by citations

Authors
Wigle, J. T., Harvey, N., Detmar, M., Lagutina, I., Grosveld, G., Gunn, M. D., Jackson, D. G., & Oliver, G.
Affiliations
  • St. Jude Children's Research Hospital (US)
  • Harvard University (US)
  • Duke University (US)
  • John Radcliffe Hospital (GB)
Corresponding author
Oliver, Guillermo
Venue
The EMBO Journal
Published
2002-04-01
Volume
21
Issue
7
Pages
1505-1513
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2096608993
Cited by
943
References
1
Citations by year
2026: 23 · 2025: 35 · 2024: 35 · 2023: 32 · 2022: 41 · 2021: 46 · 2020: 32 · 2019: 36 · 2018: 26 · 2017: 35 · 2016: 40 · 2015: 32 · 2014: 42 · 2013: 36 · 2012: 28
FWCI
19.13
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Lebanese Syrian Associated Charities (CA 21765)
  • Medical Research Council Canada
  • National Institutes of Health (CA21765))
  • Medical Research Council
  • National Eye Institute (R01EY012162, EY 12162)
  • National Cancer Institute (CA21765, P30CA021765)
  • National Institute of General Medical Sciences (GM58462, R01GM058462)
Topics
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Vascular Malformations and Hemangiomas
Keywords
Prox1, lymphatic endothelial cells, lymphangiogenesis, endothelial differentiation, VEGFR-3, LYVE-1, SLC, homeobox genes
MeSH terms
Prospero-Related Homeobox 1 Protein, Animals, Cell Differentiation, Endothelium, Vascular, Glycoproteins, Humans, Lymphatic System, Mice, Inbred BALB C, Mice, Nude, Neovascularization, Pathologic, Phenotype, Tumor Cells, Cultured, Biomarkers, Receptors, Growth Factor, Mice, Knockout, Homeodomain Proteins, Hyaluronan Receptors, Chemokines, CC, Receptor Protein-Tyrosine Kinases, Tumor Suppressor Proteins, Membrane Transport Proteins, Vesicular Transport Proteins, Vascular Endothelial Growth Factor Receptor-3, Mice, Chemokine CCL21

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review